Mutations in the VHL gene from potassium bromate-induced rat clear cell renal tumors

Cancer Letters

Volumn 187, Issue 1-2, 2002, Pages 207-214

  Shiao, Yih Horng ^a   Kamata, Sonie I ^a   Li, Leeanne M ^a   Hooth, Michelle J ^b   DeAngelo, Anthony B ^b   Anderson, Lucy M ^a   Wolf, Douglas C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Drinking water; Kidney; Von Hippel Lindau

Indexed keywords

CYTOSINE; DNA; DRINKING WATER; FORMALDEHYDE; PARAFFIN; POTASSIUM BROMATE; THYMIDINE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME MICRODISSECTION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HUMAN; KIDNEY CARCINOMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA, CLEAR CELL; ANIMALS; BROMATES; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; KIDNEY NEOPLASMS; LIGASES; MALE; MUTATION; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RATS; RATS, WISTAR; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

ANIMALIA;

EID: 0037058646     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00407-X     Document Type: Article

References (39)

1. International Agency for Research on Cancer. Potassium bromate. IARC Monogr. Eval. Carcinog. Risks. Hum. 40:1986;207-220.
2. Glaze W.H. Reaction products of ozone: a review. Environ. Health Perspect. 69:1986;151-157.
3. Cavanaugh J.E., Weinberg H.S., Gold A., Sangalah R., Marbury D., Glaze W.H., Colette T.W., Richardson S.D., Thurston A.D. Ozonation byproducts: identification of bromohydrins from the ozonation of natural waters with enhanced bromide levels. Environ. Sci. Technol. 26:1992;1658-1662.
4. 1 mice and F344/N rats. Toxicol. Pathol. 26:1998;587-594.
5. Wolf D.C., Crosby L.M., George M.H., Kilburn S.R., Moore T.M., Miller R.T., DeAngelo A.B. Time- and dose-dependent development of potassium bromate-induced tumors in male Fischer 344 rats. Toxicol. Pathol. 26:1998;724-729.
6. Kurokawa Y., Takamura N., Matsuoka C., Imazawa T., Matsushima Y., Onodera H., Hayashi Y. Comparative studies on lipid peroxidation in the kidney of rats, mice, and hamsters and on the effect of cysteine, glutathione, and diethyl maleate treatment on mortality and nephrotoxicity after administration of potassium bromate. J. Am. Coll. Toxicol. 6:1987;489-501.
7. 3), a renal oxidative carcinogen. Mutat. Res. 364:1996;227-233.
8. Sai K., Takagi A., Umemura T., Hasegawa R., Kurokawa Y. Relation of 8-hydroxydeoxyguanosine formation in rat kidney to lipid peroxidation, glutathione level and relative organ weight after a single administration of potassium bromate. Jpn. J. Cancer Res. 82:1991;165-169.
9. Cohen H.T. Advances in the molecular basis of renal neoplasia. Curr. Opin. Nephrol. Hypertens. 8:1999;325-331.
10. Fleming S. Genetics of kidney tumors. Forum. 8:1998;176-184.
11. Kaelin W.G., Maher E.R. The VHL tumour suppressor gene paradigm. Trends Genet. 14:1998;423-426.
12. Motzer R.J., Bander N.H., Nanus D.M. Renal-cell carcinoma. N. Engl. J. Med. 335:1996;865-875.
13. Steiner G., Sidransky D. Molecular differential diagnosis of renal carcinoma. Am. J. Pathol. 149:1996;1791-1795.
14. Storker S., van den Berg E. Morphological classification of renal cancer. World J. Urol. 13:1995;153-158.
15. Maher E.R., Kaelin W.G. von Hippel-Lindau Disease. Medicine. 76:1997;381-391.
16. Dorkin T.J., Robson C.N., Neal D.E. The molecular pathology of urological malignancies. J. Pathol. 183:1997;380-387.
17. Latif F., Tory K., Gnarra J., Yao M., Duh F.-M., Orcutt M. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1993;1317-1320.
18. Ohh M., Kaelin W.G. The von Hippel-Lindau tumour suppressor protein: new perspectives. Mol. Med. Today. 5:1999;257-263.
19. Zbar B., Kaelin W., Maher E., Richard S. Third international meeting on von Hippel-Lindau disease. Cancer Res. 59:1999;2251-2253.
20. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275.
21. Maxwell P.H., Pugh C.W., Ratcliffe P.J. Insights into the role of the von Hippel-Lindau gene product. A key player in hypoxic regulation. Exp. Nephrol. 9:2001;235-240.
22. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A.V., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292:2001;468-472.
23. Shiao Y.H., Rice J.M., Anderson L.M., Diwan B.A., Hard G.C. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J. Natl Cancer Inst. 90:1998;1720-1723.
24. Shiao Y.H., Ramakrishna G., Anderson L.M., Perantoni A.O., Rice J.M., Diwan B.A. Down-regulation of von Hippel-Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors. Cancer Lett. 179:2002;33-38.
25. Shiao Y.H., Diwan B.A., Perantoni A.O., Calvert R.J., Zbar B., Lerman M.I., Rice J.M. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers. Mol. Carcinog. 19:1997;230-235.
26. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:1995;4878-4884.
27. McLaughlin J.K., Lipworth L. Epidemiologic aspects of renal cell cancer. Semin. Oncol. 27:2000;115-123.
28. Vamvakas S., Bruning T., Thomasson B., Lammert M., Baumuller A., Bolt H.M., Dekant W., Birner G., Henschler D., Ulm K. Renal cell cancer correlated with occupational exposure to trichloroethene. Cancer Res. Clin. Oncol. 124:1998;374-382.
29. Brauch H., Weirich G., Hornauer M.A., Storkel S., Wohl T., Bruning T. Trichoroethlene exposure and specific somatic mutations in patients with renal cell carcinoma. J. Natl Inst. Cancer. 91:1999;854-861.
30. De Vriese A., Vanholder R., Lameire N. Severe acute renal failure due to bromate intoxication: report of a case and discussion of management guidelines based on a review of the literature. Nephrol. Dial. Transplant. 12:1997;204-209.
31. Kurokawa Y., Maekawa A., Takahashi M., Hayashi Y. Toxicity and carcinogenicity of potassium bromate - A new renal carcinogen. Environ. Health Perspect. 87:1990;309-335.
32. Niwa T., Ito T., Matsui E. Serial renal biopsy in potassium bromate intoxication. Jpn. Circ. J. 38:1974;387-392.
33. Konishi N., Hiasa Y. Renal carcinogenesis. Waalkes M.P., Ward J.M., Carcinogenesis. 1994;123-159 Raven Press, New York, NY.
34. Shiao Y.H., Resau J.H., Nagashima K., Anderson L.M., Ramakrishna G. The von Hippel-Lindau tumor suppressor targets to mitochondria. Cancer Res. 60:2000;2816-2819.
35. Suen W., Spiro T.G., Sowers L.C., Fresco J.R. Identification by UV resonance Raman spectroscopy of an imino tautomer of 5-hydroxy-2′-deoxycytidine, a powerful base analog transition mutagen with a much higher unfavored tautomer frequency than that of the natural residue 2′-deoxycytidine. Proc. Natl Acad. Sci. USA. 96:1999;4500-4505.
36. Cook T., Gebelein B., Urrutia R. Sp1 and its likes: biological and functional predictions for a growing family of zinc finger transcription factors. Ann. N. Y. Acad. Sci. 880:1999;94-102.
37. Walker C.L., Ahn Y.T., Everitt J.I., Yuan X. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Mol. Carcinog. 15:1996;154-161.
38. Urakami S., Tokuzen R., Tsuda H., Igawa M., Hino O. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma. J. Urol. 158:1997;275-278.
39. Toyokuni S., Okada K., Kondo S., Nishioka H., Tanaka T., Nishiyama Y., Hino O., Hiai H. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes. Jpn. J. Cancer Res. 89:1998;814-820.